Business

The unicorn surgical robotics maker will use the funds to further expand into China and overseas while developing new products.

The company recently presented clinical data at the European Society for Medical Oncology Congress for an investigational drug that displayed anti-tumor activity and a good safety profile.

Tom Gillette, Mount Sinai Medical Center's CIO, discusses how Spanish-language AI, predictive models and remote patient monitoring are boosting patient engagement and care access for its diverse South Florida community.

Daryl Tol, president of General Catalyst’s Health Assurance Transformation Company (HATCo), shares an update on the current state of the venture firm’s healthcare system.

The funds will be used to further invest in its product innovation, including its Polaris Safety Constellation Architecture, and to merge with or purchase other companies.

The company will use the funds to expand its in-house operations in New York and San Diego, as well as accelerate the trials and commercialization of its BCI.

Government regulation can slow health systems' AI progress; Ed Marx, Marx Advisory CEO, says showing policymakers AI's real-world benefits in person can help them understand its value more than traditional lobbying.

Lisa Suennen, managing partner at American Heart Association Ventures, and Ruby Gadelrab, CEO and founder of MDisrupt, explores next steps after AHA's $1 million milestone investment into MDisrupt, including plans to co-develop a platform.

The increase in adjusted gross margin was related to a rise in average selling price and a decrease in software amortization costs for the company's software development investments.

Dr. Daniela Carvalho, pediatric otolaryngologist at Rady Children's Health in San Diego, shares insights on performing California's first pediatric Nucleus Nexa cochlear implant and what this means for the future of pediatric hearing care.